Details of the Drug | DrugMAP

General Information of Drug (ID: DMON7OL)

Drug Name

Apo805K1

Indication

Disease Entry	ICD 11	Status	REF
Psoriasis vulgaris	EA90	Phase 2	[1]
------------------------------------------------------------------------------------

Structure

3D MOL is unavailable

2D MOL

Chemical Identifiers

Formula: C16H18KN3O5
Canonical SMILES: [H+].C1=CC=C2C(=C1)C(=CN2)CC(C(=O)[O-])NC(=O)CCC(C(=O)[O-])N.[K+]
InChI: 1S/C16H19N3O5.K/c17-11(15(21)22)5-6-14(20)19-13(16(23)24)7-9-8-18-12-4-2-1-3-10(9)12;/h1-4,8,11,13,18H,5-7,17H2,(H,19,20)(H,21,22)(H,23,24);/q;+1/p-1/t11-,13-;/m1./s1
InChIKey: JBUWHGCMOSDECA-LOCPCMAASA-M

Cross-matching ID

PubChem CID: 76318569
CAS Number: 960155-19-5
TTD ID: D06HQM

References

1	ClinicalTrials.gov (NCT01483924) Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis. U.S. National Institutes of Health.